Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma.
Hepatosplenic T-cell lymphoma (HSTL) is an aggressive lymphoma cytogenetically characterized by isochromosome 7q [i(7)(q10)], of which the molecular consequences remain unknown. We report here results of an integrative genomic and transcriptomic (expression microarray and RNA-sequencing) study of si...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/57923d7ea5bf4defbf70b289ded67d4f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:57923d7ea5bf4defbf70b289ded67d4f |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:57923d7ea5bf4defbf70b289ded67d4f2021-11-25T06:07:21ZIntegrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma.1932-620310.1371/journal.pone.0102977https://doaj.org/article/57923d7ea5bf4defbf70b289ded67d4f2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25057852/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Hepatosplenic T-cell lymphoma (HSTL) is an aggressive lymphoma cytogenetically characterized by isochromosome 7q [i(7)(q10)], of which the molecular consequences remain unknown. We report here results of an integrative genomic and transcriptomic (expression microarray and RNA-sequencing) study of six i(7)(q10)-positive HSTL cases, including HSTL-derived cell line (DERL-2), and three cases with ring 7 [r(7)], the recently identified rare variant aberration. Using high resolution array CGH, we profiled all cases and mapped the common deleted region (CDR) at 7p22.1p14.1 (34.88 Mb; 3506316-38406226 bp) and the common gained region (CGR) at 7q22.11q31.1 (38.77 Mb; 86259620-124892276 bp). Interestingly, CDR spans a smaller region of 13 Mb (86259620-99271246 bp) constantly amplified in cases with r(7). In addition, we found that TCRG (7p14.1) and TCRB (7q32) are involved in formation of r(7), which seems to be a byproduct of illegitimate somatic rearrangement of both loci. Further transcriptomic analysis has not identified any CDR-related candidate tumor suppressor gene. Instead, loss of 7p22.1p14.1 correlated with an enhanced expression of CHN2 (7p14.1) and the encoded β2-chimerin. Gain and amplification of 7q22.11q31.1 are associated with an increased expression of several genes postulated to be implicated in cancer, including RUNDC3B, PPP1R9A and ABCB1, a known multidrug resistance gene. RNA-sequencing did not identify any disease-defining mutation or gene fusion. Thus, chromosome 7 imbalances remain the only driver events detected in this tumor. We hypothesize that the Δ7p22.1p14.1-associated enhanced expression of CHN2/β2-chimerin leads to downmodulation of the NFAT pathway and a proliferative response, while upregulation of the CGR-related genes provides growth advantage for neoplastic δγT-cells and underlies their intrinsic chemoresistance. Finally, our study confirms the previously described gene expression profile of HSTL and identifies a set of 24 genes, including three located on chromosome 7 (CHN2, ABCB1 and PPP1R9A), distinguishing HSTL from other malignancies.Julio Finalet FerreiroLeila RouhigharabaeiHelena UrbankovaJo-Anne van der KrogtLucienne MichauxShashirekha ShettyLaszlo KrenacsThomas TousseynPascale De PaepeAnne UyttebroeckGregor VerhoefTom TaghonPeter VandenbergheJan CoolsIwona WlodarskaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 7, p e102977 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Julio Finalet Ferreiro Leila Rouhigharabaei Helena Urbankova Jo-Anne van der Krogt Lucienne Michaux Shashirekha Shetty Laszlo Krenacs Thomas Tousseyn Pascale De Paepe Anne Uyttebroeck Gregor Verhoef Tom Taghon Peter Vandenberghe Jan Cools Iwona Wlodarska Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| description |
Hepatosplenic T-cell lymphoma (HSTL) is an aggressive lymphoma cytogenetically characterized by isochromosome 7q [i(7)(q10)], of which the molecular consequences remain unknown. We report here results of an integrative genomic and transcriptomic (expression microarray and RNA-sequencing) study of six i(7)(q10)-positive HSTL cases, including HSTL-derived cell line (DERL-2), and three cases with ring 7 [r(7)], the recently identified rare variant aberration. Using high resolution array CGH, we profiled all cases and mapped the common deleted region (CDR) at 7p22.1p14.1 (34.88 Mb; 3506316-38406226 bp) and the common gained region (CGR) at 7q22.11q31.1 (38.77 Mb; 86259620-124892276 bp). Interestingly, CDR spans a smaller region of 13 Mb (86259620-99271246 bp) constantly amplified in cases with r(7). In addition, we found that TCRG (7p14.1) and TCRB (7q32) are involved in formation of r(7), which seems to be a byproduct of illegitimate somatic rearrangement of both loci. Further transcriptomic analysis has not identified any CDR-related candidate tumor suppressor gene. Instead, loss of 7p22.1p14.1 correlated with an enhanced expression of CHN2 (7p14.1) and the encoded β2-chimerin. Gain and amplification of 7q22.11q31.1 are associated with an increased expression of several genes postulated to be implicated in cancer, including RUNDC3B, PPP1R9A and ABCB1, a known multidrug resistance gene. RNA-sequencing did not identify any disease-defining mutation or gene fusion. Thus, chromosome 7 imbalances remain the only driver events detected in this tumor. We hypothesize that the Δ7p22.1p14.1-associated enhanced expression of CHN2/β2-chimerin leads to downmodulation of the NFAT pathway and a proliferative response, while upregulation of the CGR-related genes provides growth advantage for neoplastic δγT-cells and underlies their intrinsic chemoresistance. Finally, our study confirms the previously described gene expression profile of HSTL and identifies a set of 24 genes, including three located on chromosome 7 (CHN2, ABCB1 and PPP1R9A), distinguishing HSTL from other malignancies. |
| format |
article |
| author |
Julio Finalet Ferreiro Leila Rouhigharabaei Helena Urbankova Jo-Anne van der Krogt Lucienne Michaux Shashirekha Shetty Laszlo Krenacs Thomas Tousseyn Pascale De Paepe Anne Uyttebroeck Gregor Verhoef Tom Taghon Peter Vandenberghe Jan Cools Iwona Wlodarska |
| author_facet |
Julio Finalet Ferreiro Leila Rouhigharabaei Helena Urbankova Jo-Anne van der Krogt Lucienne Michaux Shashirekha Shetty Laszlo Krenacs Thomas Tousseyn Pascale De Paepe Anne Uyttebroeck Gregor Verhoef Tom Taghon Peter Vandenberghe Jan Cools Iwona Wlodarska |
| author_sort |
Julio Finalet Ferreiro |
| title |
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| title_short |
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| title_full |
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| title_fullStr |
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| title_full_unstemmed |
Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. |
| title_sort |
integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic t-cell lymphoma. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/57923d7ea5bf4defbf70b289ded67d4f |
| work_keys_str_mv |
AT juliofinaletferreiro integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT leilarouhigharabaei integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT helenaurbankova integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT joannevanderkrogt integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT luciennemichaux integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT shashirekhashetty integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT laszlokrenacs integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT thomastousseyn integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT pascaledepaepe integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT anneuyttebroeck integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT gregorverhoef integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT tomtaghon integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT petervandenberghe integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT jancools integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma AT iwonawlodarska integrativegenomicandtranscriptomicanalysisidentifiedcandidategenesimplicatedinthepathogenesisofhepatosplenictcelllymphoma |
| _version_ |
1718414163230851072 |